Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification

BACKGROUND AND AIM: Chemotherapy with streptozocin (STZ) in combination with 5-FU or doxorubicin (Dox) represents a standard of care for patients with metastatic pancreatic neuroendocrine neoplasms (pNEN). However, predictive markers for patient selection are still missing. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Krug, Sebastian, Boch, Michael, Daniel, Hanna, Nimphius, Wilhelm, Müller, Daniela, Michl, Patrick, Rinke, Anja, Gress, Thomas Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668106/
https://www.ncbi.nlm.nih.gov/pubmed/26630134
http://dx.doi.org/10.1371/journal.pone.0143822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668106/
https://www.ncbi.nlm.nih.gov/pubmed/26630134
http://dx.doi.org/10.1371/journal.pone.0143822

Ejemplares similares